TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma

Ilari Mäki‐Opas, Morena Scotece|Arthritis Research & Therapy|2023

Cited by 10